{
    "Case ID": "058784",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent validity and infringement"
    ],
    "Legal_Issue": [
        "Validity of the '637 Patent and whether Apotex's formulation infringes it"
    ],
    "Governing_Law": [
        "Patent Act"
    ],
    "Procedural_Stage": [
        "Pre-approval litigation under regulatory process"
    ],
    "Evidence_Assessment": [
        "Expert evidence on technical feasibility of avoiding pink hue by eliminating water"
    ],
    "Decision_Outcome": [
        "'637 Patent found invalid due to anticipation; infringement established if valid"
    ],
    "Burden_of_Proof": [
        "On SmithKline to justify injunction; on Apotex to challenge validity"
    ],
    "Credibility_Factor": [
        "Expert testimony on pharmaceutical formulation and prior art interpretation"
    ],
    "Legal_Rule": [
        "A patent must be novel, non-obvious, and useful; novelty under Section 28.2(1), obviousness under Section 28.3"
    ],
    "Standard_of_Review": [
        "Statutory interpretation and factual assessment based on balance of probabilities"
    ],
    "Procedural_Issue": [
        "Application for prohibition order against regulatory approval"
    ],
    "Grounds_for_Claim": [
        "Alleged infringement of '637 Patent by Apotex's generic paroxetine tablets"
    ],
    "Outcome_on_Merits": [
        "SmithKline's application dismissed"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "No injunction granted"
    ],
    "Review_Standard": [
        "Interpretation of Patent Act and examination of prior art ('060 Patent)"
    ],
    "Procedural_Fairness_Assessment": [
        "Fair hearing provided in pre-approval dispute"
    ],
    "Key_Evidence_Considered": [
        "Disclosure in '060 Patent; expert analysis on solving pink hue issue"
    ],
    "Legal_Framework": [
        "Regulatory and patent law framework governing drug approval and patent protection"
    ],
    "Applicant_Challenge": [
        "SmithKline challenged Health Canada's potential approval of Apotex's generic"
    ],
    "Court_Result": [
        "Dismissal of SmithKline's application"
    ],
    "Legal_Rule_Source": [
        "Patent Act, Sections 28.2(1) and 28.3"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Apotex alleged non-infringement and invalidity of the '637 Patent"
    ],
    "Evidence_Type": [
        "Documentary (patents), expert testimony"
    ],
    "Remedy_Requested": [
        "Order prohibiting Health Canada from approving Apotex's application"
    ],
    "Outcome": [
        "Remedy denied"
    ],
    "Decision_Authority": [
        "Federal Court or relevant Canadian court with jurisdiction"
    ],
    "Remedy_Sought": [
        "Injunction until patent expiry"
    ],
    "Resolution_Mechanism": [
        "Judicial determination on validity and infringement"
    ],
    "Legal_Provision": [
        "Section 28.2(1), Section 28.3 of the Patent Act"
    ],
    "Authority": [
        "Canadian courts"
    ],
    "Claimant_Status": [
        "Patent holder (SmithKline)"
    ],
    "Legal_Provision_Cited": [
        "Patent Act, s. 28.2(1), s. 28.3"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Anticipation by prior art ('060 Patent)"
    ],
    "Applicable_Process": [
        "Notice of Compliance (NOC) proceedings under Canadian patent linkage regime"
    ],
    "Outcome_of_Review": [
        "Invalidity established, no stay of approval issued"
    ],
    "Pending_Relief_or_Application": [
        "Application for prohibition order pending decision"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Patent Act provisions on novelty and obviousness"
    ]
}